Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Phylogica, Notice of Annual General Meeting and Explanatory Statement (ASX:PYC)

Notice is hereby given that the Annual General Meeting of the Shareholders of Phylogica Limited will be held at Level 5, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, Western Australia ...read more

Phylogica, Corporate Governance Statement and Appendix 4G (ASX:PYC)

ASX Corporate Governance Council Principles and Recommendations Our Company has adopted comprehensive systems of control and accountability as the basis for the administration of corporate governan...read more

Phylogica, Annual Report for the Year Ended 30 June 2018 (ASX:PYC)

Overview of progress in FY18 As a brief recap, major achievements through FY18 included: 1. An investment in our peptide libraries to triple their diversity and therefore richness as a source of...read more

Phylogica Announces R&D Tax Incentive Refund (ASX:PYC)

PERTH, Australia, 8th October 2018: Phylogica Limited (ASX:PYC) (Phylogica or the Company), advises that it has received a $2,900,000 cash refund under the Federal Government’s R&D Tax Incen...read more

Phylogica, Appendix 3Y (ASX:PYC)

Change of Director’s Interest Notice Alan William Tribe To view Notice please download PDF attached:

Phylogica, Appendix 3B, New Issue Announcement (ASX:PYC)

Please find attached and Appendix 3B and Section 708A Notice in respect of the issue of 146,166,674 ordinary fully paid shares issued pursuant to the share placement announced to ASX on 11 September 2...read more

Phylogica, Annual Financial Report 30 June 2018 (ASX:PYC)

The directors present their report on the consolidated group, comprising Phylogica Limited (referred to in these financial statements as “the Group” or “Phylogica”) and its who...read more

Phylogica, Reinstatement to Official Quotation (ASX:PYC)

The suspension of trading in the securities of Phylogica Limited (‘PYC’) will be lifted from the commencement of trading today, Wednesday, 12 September 2018, following the release by PYC o...read more

Phylogica Announces Re-capitalisation (ASX:PYC)

Phylogica is pleased to announce that it has received firm commitments to raise $9.12 m (before costs) through a placement of shares to both new and existing sophisticated and institutional investors ...read more

Phylogica, Suspension from Official Quotation (ASX:PYC)

We refer to our request for a trading halt dated 7 September 2018. Phylogica Limited (“Phylogica, the Company”) requests that the ASX grant a voluntary suspension in the Company’s...read more

Phylogica Announces Update on Capital Raising (ASX:PYC)

Phylogica provides the following update in relation to its current capital raising. The capital raising: - is being conducted at a price of 3 cents per share; - is an excluded offer available...read more

Phylogica, Trading Halt (ASX:PYC)

In accordance with Listing Rule 17.1, Phylogica Limited requests that an immediate trading halt be placed on its securities pending an announcement to the market regarding a proposed capital raising t...read more

Phylogica, Appendix 4E, Preliminary Final Report - Year Ended 30 June 2018 (ASX:PYC)

DIRECTORS’ COMMENTARY The principal activity of the Company during the financial year was research and development. Phylogica owns a delivery platform that enables drug cargoes to reach targe...read more

Phylogica Announces Platform Described in Nature - Scientific Reports (ASX:PYC)

Phylogica is pleased to announce a peer-reviewed publication on our proprietary Cell Penetrating Peptide (CPP) platform in Nature Scientific Reports. The article describes the ability of Phylogica&rsq...read more

Phylogica Announces Article: Delivering Cancer Treatment Inside Cells - Nature Oncogene (ASX:PYC)

6 August 2018: Phylogica is pleased to announce the publication of an article in Nature Oncogene by A/Prof Pilar Blancafort describing the impact of Phylogica’s Cell Penetrating Peptides (CPPs) ...read more

Viewing: 1 - 15 of 116 Previous | Next